Career Enhancement Core of GLIA-CTN
GLIA-CTN 职业提升核心
基本信息
- 批准号:10266091
- 负责人:
- 金额:$ 12.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdvocacyAdvocateAffectAwardAwarenessCaringClinicalClinical InvestigatorClinical ResearchClinical SkillsClinical TrialsClinical Trials NetworkCommunitiesCommunity OutreachDevelopmentDiagnosisEducationEducation and OutreachFamilyFamily CaregiverFinancial SupportFoundationsFundingGenomicsGeographic LocationsGoalsGuidelinesHealthIndividualIndustryInformation DisseminationInstitutionKnowledgeLettersMagnetic Resonance ImagingMentorshipMissionOutcomePatientsPattern RecognitionPilot ProjectsProcessProgram DevelopmentProviderPublishingRecommendationResearchResearch PersonnelResolutionScientistSiteStructureTherapeuticTrainingTraining ProgramsTranslational ResearchTravelWagesWorkcare providerscareercareer developmentclinical careclinical centerclinical trial readinesshealth disparityimprovedindividual patientinterestleukodystrophymedical specialtiesmembernext generationpatient advocacy groupprogramssymposium
项目摘要
Abstract
The Global Leukodystrophy Initiative (GLIA) has made education and improved standards of care a key
aspect of their mission. We acknowledge the importance of education and outreach related to the
leukodystrophies across stakeholders, including patients, families, primary care providers and specialty
providers. The GLIA consortium has published the only current comprehensive recommendations for
standards of care across these conditions. Our investigators and their institutions have a longstanding
commitment to educational efforts and community outreach. Advocacy partners participating in the GLIA
Clinical Trials Network (GLIA-CTN) are also strong advocates for improved education. The GLIA-CTN career
development program will leverage the input of the patient advocacy groups and our investigators to enhance
knowledge of leukodystrophies within the community. Although a full resolution of educational needs in the
leukodystrophy community is beyond the scope of this application, the GLIA-CTN will lay the groundwork for
development of a multi-stakeholder educational approach through the following aims:
Educational Aim 1: to develop a process to integrate relevant stakeholder input on development of
educational programs including clinicians, researchers, patients and their families/ caregivers.
Educational Aim 2: to establish a clinical investigator training program in the leukodystrophies to attract and
train the next generation of researchers to advancing the care of individuals affected by the leukodystrophies.
抽象的
全球脑白质营养不良倡议 (GLIA) 将教育和提高护理标准作为关键
他们使命的一个方面。我们认识到与以下方面相关的教育和宣传的重要性
脑白质营养不良涉及患者、家庭、初级保健提供者和专业人士等利益相关者
提供商。 GLIA 联盟发布了当前唯一的综合建议
这些条件下的护理标准。我们的研究人员及其机构有着悠久的历史
致力于教育工作和社区外展。参与 GLIA 的倡导合作伙伴
临床试验网络 (GLIA-CTN) 也是改善教育的强烈倡导者。 GLIA-CTN 职业生涯
开发计划将利用患者倡导团体和我们的研究人员的意见来加强
社区内脑白质营养不良的知识。虽然全面解决了教育需求
脑白质营养不良群体超出了本申请的范围,GLIA-CTN 将为
通过以下目标制定多利益相关者教育方法:
教育目标 1:制定一个流程,整合相关利益相关者对发展的投入
教育计划,包括临床医生、研究人员、患者及其家人/护理人员。
教育目标 2:建立脑白质营养不良临床研究者培训计划,以吸引和
培训下一代研究人员,以推进对脑白质营养不良患者的护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adeline Lucie Vanderver其他文献
Adeline Lucie Vanderver的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adeline Lucie Vanderver', 18)}}的其他基金
Reverse transcriptase inhibition as a novel therapeutic approach for ADAR-1-related Aicardi Goutières Syndrome
逆转录酶抑制作为 ADAR-1 相关 Aicardi Goutières 综合征的新型治疗方法
- 批准号:
10288270 - 财政年份:2022
- 资助金额:
$ 12.45万 - 项目类别:
Improved clinical and biologic outcome measures in Aicardi Goutieres Syndrome
改善 Aicardi Goutieres 综合征的临床和生物学结果测量
- 批准号:
10442673 - 财政年份:2019
- 资助金额:
$ 12.45万 - 项目类别:
Improved clinical and biologic outcome measures in Aicardi Goutieres Syndrome
改善 Aicardi Goutieres 综合征的临床和生物学结果测量
- 批准号:
10675475 - 财政年份:2019
- 资助金额:
$ 12.45万 - 项目类别:
Optimizing Trial Readiness for Adrenomyeloneuropathy
优化肾上腺脊髓神经病的试验准备
- 批准号:
10266086 - 财政年份:2019
- 资助金额:
$ 12.45万 - 项目类别:
Optimizing Trial Readiness for Adrenomyeloneuropathy
优化肾上腺脊髓神经病的试验准备
- 批准号:
10442670 - 财政年份:2019
- 资助金额:
$ 12.45万 - 项目类别:
: Clinical Outcomes in Aicardi Goutières Syndrome
: Aicardi Goutières 综合征的临床结果
- 批准号:
10459505 - 财政年份:2019
- 资助金额:
$ 12.45万 - 项目类别:
相似海外基金
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 12.45万 - 项目类别:
Examining Individuals' Exposure to Alcohol Environments Using Novel Responsive Buffers
使用新型响应缓冲器检查个人对酒精环境的暴露情况
- 批准号:
10752468 - 财政年份:2023
- 资助金额:
$ 12.45万 - 项目类别:
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
胆管癌会议:分子驱动因素、微环境和精准医学
- 批准号:
10747566 - 财政年份:2023
- 资助金额:
$ 12.45万 - 项目类别:
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 12.45万 - 项目类别: